Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the detailed record of transactions filed by 聂在建, Directeur. Officer active across 1 company, notably 三元生物. Cumulatively, 1 filings have been published. History available since 19 July 2024. The latest transaction was filed on 19 July 2024 (Purchase). Regulator: SSE / SZSE (CSRC). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Nie Zaijian is a Director at Sanyuan Biotechnology, where he plays an essential role in the company's strategy and decision-making. With expertise in the sector, he is involved in developing new projects and improving operations. His leadership is crucial for the company's success.